CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q4 2023 vs. Q3 2023
How the institutions holding CDT Equity Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 3 | 11 | +8 |
| Shares | 5.35K | 1.38M | +1.37M (+25,587.6%) |
| Value | $32.0K | $6.26M | +$6.23M (+19,472.1%) |
New holders (11)
Institutions that held CDT Equity Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 804,292 | $3.66M | 0.00% |
| Vanguard Group Inc | 236,257 | $1.07M | 0.00% |
| Geode Capital Management, LLC | 139,640 | $635.5K | 0.00% |
| BlackRock Inc. | 137,962 | $627.7K | 0.00% |
| Northern Trust Corp | 21,176 | $96.4K | 0.00% |
| Citadel Advisors LLC | 16,574 | $75.4K | 0.00% |
| Bank of Montreal | 10,000 | $52.3K | 0.00% |
| JPMorgan Chase & Co | 6,412 | $29.2K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,115 | $9.62K | 0.00% |
| Bank of America Corp | 557 | $2.53K | 0.00% |
| Wells Fargo & Company | 72 | $328 | 0.00% |
Sold out (3)
Institutions that held CDT Equity Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| UBS Group AG | 3,828 | $22.9K |
| Kepos Capital LP | 1,500 | $9.00K |
| Morgan Stanley | 25 | $149 |